SGMO stock rated a Sector perform by RBC Capital Mkts
Sangamo Therapeutics Inc’s filing revealed that its 10% Owner BIOGEN INC. unloaded Company’s shares for reported $3.0 million on Sep 26 ’23. In the deal valued at $0.50 per share,6,000,000 shares were sold. As a result of this transaction, BIOGEN INC. now holds 17,652,466 shares worth roughly $11.3 million. RBC Capital Mkts downgraded its Sangamo […]
